Literature DB >> 25493913

First-in-man report of residual "intra-clip" regurgitation between two MitraClips treated by AMPLATZER Vascular Plug II.

Maurizio Taramasso1, Michel Zuber, Christiane Gruner, Oliver Gaemperli, Fabian Nietlispach, Francesco Maisano.   

Abstract

AIMS: We present here the first-in-man case report of a patient with a significant residual "intra-clip" jet treated by the implantation of an AMPLATZER Vascular Plug II. METHODS AND
RESULTS: A 64-year-old gentleman came to our attention for mitral regurgitation (MR) recurrence four years after transcatheter mitral repair with MitraClip. After the implantation of two further MitraClips, residual intra-clip MR was present, without room for a further clip. An AMPLATZER Vascular Plug II was successfully deployed between the two clips. Final echocardiography showed residual mild MR, without any sign of mitral stenosis.
CONCLUSIONS: This case demonstrates the feasibility of the implantation of an AMPLATZER Vascular Plug between two MitraClips to treat significant residual "intra-clip" MR, when the implantation of an adjunctive clip is not feasible. This approach may represent an effective therapeutic solution in case of a significant residual intra-clip jet.

Entities:  

Mesh:

Year:  2016        PMID: 25493913     DOI: 10.4244/EIJY14M12_04

Source DB:  PubMed          Journal:  EuroIntervention        ISSN: 1774-024X            Impact factor:   6.534


  2 in total

1.  Implantation of a MitraClip between two previously implanted MitraClips to treat recurrent severe mitral regurgitation.

Authors:  Hasema Lesevic; Carolin Sonne; Albert Markus Kasel; Dietmar Breuer; Adnan Kastrati; Heribert Schunkert; Ilka Ott
Journal:  J Cardiol Cases       Date:  2016-11-17

2.  Bail-out use of the Amplatzer Septal Occluder for treatment of acute iatrogenic leaflet perforation during the MitraClip procedure in a patient with functional mitral regurgitation.

Authors:  Adrian Kłapyta; Jerzy Pręgowski; Zbigniew Chmielak; Piotr Szymański; Adam Witkowski; Marcin Demkow
Journal:  Postepy Kardiol Interwencyjnej       Date:  2018-09-21       Impact factor: 1.426

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.